Track the Peak Bio, Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 4 December 2024 (J). Among the most active insiders: Huh Hoyoung. Every trade is accessible without an account.
20
Insider Decl.
n/a
Thresholds
€1,265
10 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Peak Bio, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
15Σ signal
Buys €1,265n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.